English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/207900
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:


VPS13A is closely associated with mitochondria and is required for efficient lysosomal degradation

AuthorsMuñoz-Braceras, Sandra ; Tornero, Alba Rocío; Vincent, Olivier ; Escalante, Ricardo
Membrane contact sites
Issue Date22-Feb-2019
PublisherCompany of Biologists
CitationDMM Disease Models and Mechanisms 12 (2019)
AbstractMembers of the VPS13 family are associated with various human diseases. In particular, the loss of function of VPS13A leads to chorea-acanthocytosis (ChAc), a rare neurodegenerative disease without available curative treatments. Autophagy has been considered a promising therapeutic target because the absence of VPS13A causes a defective autophagy flux. However, the mechanistic details of this deficiency are unknown. Here, we identified Rab7A as an interactor of one of the VPS13 family members in Dictyostelium discoideum and showed that this interaction is conserved between the human homologs VPS13A and RAB7A in HeLa cells. As RAB7A is a key player in endosome trafficking, we addressed the possible function of VPS13A in endosome dynamics and lysosome degradation. Our results suggest that the decrease in autophagy observed in the absence of VPS13A may be the result of a more general defect in endocytic trafficking and lysosomal degradation. Unexpectedly, we found that VPS13A is closely localized to mitochondria, suggesting that the role of VPS13A in the endolysosomal pathway might be related to inter-organelle communication. We show that VPS13A localizes at the interface between mitochondria-endosomes and mitochondria-endoplasmic reticulum and that the presence of membrane contact sites is altered in the absence of VPS13A. Based on these findings, we propose that therapeutic strategies aimed at modulating the endolysosomal pathway could be beneficial in the treatment of ChAc.
Publisher version (URL)http://dx.doi.org/10.1242/dmm.036681
Appears in Collections:(IIBM) Artículos
Files in This Item:
File Description SizeFormat 
VPS13A_Muñoz_Braceras_Art2019.pdf11,44 MBAdobe PDFThumbnail
Show full item record
Review this work

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.